Affymax inks deal to supply Omontys (peginesatide) to Fresenius in the U.S. PDF Print
Businessweek: The supply deal provides for discounts and rebates. Fresenius agreed to use Omontys at more than 100 U.S. dialysis centers within the next few weeks, and it may expand use of the drug from there. The companies did not disclose financial terms of the agreement, which is scheduled to end in April.

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.